A CLINICAL EVALUATION OF HYPERKALAEMIA IN PATIENTS WITH RENAL IMPAIRMENT ON COMBINATION THERAPY OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN-RECEPTOR BLOCKER

被引：0
|
作者：
Goh, T. H. [1 ]
Tan, S. C. [1 ]
Fook-Chong, S. M. C. [1 ]
Wong, K. S. [1 ]
Chan, C. M. [1 ]
机构：
[1] Singapore Gen Hosp, Singapore, Singapore
来源：
NEPHROLOGY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A139 / A139
页数：1
相关论文
共 50 条
  • [31] Role of Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in the prevention of progression of renal disease
    Ram C.V.S.
    Vergne-Marini P.
    Current Hypertension Reports, 1999, 1 (5) : 431 - 435
  • [32] ACE inhibitor and angiotensin-receptor blocker - A deadly combination
    不详
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2011, 2 (04) : 311 - U159
  • [33] Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis
    Zhao, Mingming
    Wang, Rumeng
    Yu, Yi
    Chang, Meiying
    Ma, Sijia
    Zhang, Hanwen
    Qu, Hua
    Zhang, Yu
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [34] Kidney Outcomes Following Angiotensin Receptor-Neprilysin Inhibitor vs Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy for Thrombotic Microangiopathy
    Li, Jianbo
    Liu, Qinghua
    Lian, Xingji
    Yang, Shicong
    Lian, Rong
    Li, Wenchuan
    Yu, Jianwen
    Huang, Fengxian
    Chen, Wenfang
    He, Feng
    Chen, Wei
    JAMA NETWORK OPEN, 2024, 7 (09)
  • [35] Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With Proteinuria
    Chu, Chi D.
    Powe, Neil R.
    Estrella, Michelle M.
    Shlipak, Michael G.
    McCoy, Ian E.
    Tuot, Delphine S.
    MAYO CLINIC PROCEEDINGS, 2022, 97 (11) : 2099 - 2106
  • [36] Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide
    Sata, N
    Tanaka, Y
    Suzuki, S
    Kamimura, R
    Mifune, H
    Nakamura, K
    Miyahara, K
    Arima, T
    CIRCULATION JOURNAL, 2003, 67 (12) : 1053 - 1058
  • [37] Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
    Jun, Hye-Ran
    Kim, Hyunah
    Lee, Seung-Hwan
    Cho, Jae Hyoung
    Lee, Hyunyong
    Yim, Hyeon Woo
    Yoon, Kun-Ho
    Kim, Hun-Sung
    CARDIOVASCULAR THERAPEUTICS, 2021, 2021
  • [38] Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
    Zhang, Chao
    Zhong, Jun
    Chen, Wei-Xiang
    Zhang, Xu-Yang
    Li, Yu-Hong
    Zhou, Teng-Yuan
    Zou, Yong-Jie
    Lan, Chuan
    Li, Lan
    Lai, Zhao-Pan
    Feng, Hua
    Hu, Rong
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 355 - 363
  • [39] Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis
    Shen, Jenny I.
    Saxena, Anjali B.
    Montez-Rath, Maria E.
    Chang, Tara I.
    Winkelmayer, Wolfgang C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (05) : 862 - 869
  • [40] Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin-Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure
    Albert, Nancy M.
    Swindle, Jason P.
    Buysman, Erin K.
    Chang, Chunlan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (09):
12345